Management of Herpangina
Herpangina is a self-limited viral infection requiring primarily supportive care, with treatment focused on symptom relief through adequate hydration, pain management with topical agents like benzydamine spray, and antipyretics for fever control. 1, 2
Diagnosis and Clinical Recognition
Herpangina is diagnosed based on:
- Epidemiological history of exposure to enterovirus (Coxsackievirus-A, Enterovirus-A, Echovirus) 2
- Characteristic pharyngeal lesions: small vesicles and ulcers on the soft palate, uvula, tonsillar pillars, and posterior pharynx 2
- Typical symptoms: acute onset of fever, sore throat, painful swallowing, and refusal to eat 1, 2
- Virological confirmation via PCR when needed, though clinical diagnosis is usually sufficient 1, 2
The disease predominantly affects young children under 7 years of age and follows a predictable course of 4-6 days with excellent prognosis 2, 3.
Core Treatment Approach
Supportive Care (Primary Management)
Adequate rehydration is essential, as painful oral lesions lead to decreased fluid intake 1
Dietary modifications include:
- Exclusion of salty, spicy, and fried foods that irritate lesions 1
- Offering cool, soft foods and liquids to minimize discomfort 1
Activity restrictions:
- Limitation of physical activity during acute illness 1
- Exclusion of thermal procedures (hot baths, saunas) 1
Symptomatic Pharmacological Management
Topical pain relief is the cornerstone of symptomatic treatment:
- Benzydamine spray (0.255 mg/dose): 6 doses 3 times daily, applied topically on demand for local analgesia 1
- This provides direct mucosal pain relief and reduces inflammation 1
Systemic antipyretics for fever management as needed 2
Antiviral Considerations
While broad-spectrum antivirals like ribavirin have been used, their efficacy is limited 3. However, some evidence supports:
- Inosine pranobex (Groprinosin): 50 mg/kg/day divided into doses (approximately 1 tablet of 500 mg per 10 kg body weight) for 7 days may accelerate recovery 1
- This represents an immunomodulatory approach rather than direct antiviral action 1
Chinese herbal injections (RDN, SHL, TRQ, XYP, YHN) have shown superior outcomes compared to ribavirin in some studies, though these are not standard in Western practice 3
Expected Clinical Course
- Peak viral titers occur in the first 24 hours after lesion onset 4
- Complete resolution typically occurs by day 10 from disease onset 1
- Natural healing begins within the first 24 hours, making early symptomatic intervention most beneficial 4
- Prognosis is excellent with rare complications 2
Key Clinical Pitfalls
Avoid unnecessary antibiotics: Herpangina is viral and does not require antibacterial therapy unless secondary bacterial infection develops 2
Monitor for dehydration: Young children with painful oral lesions are at risk for inadequate fluid intake requiring close monitoring 1
Distinguish from other vesicular diseases: Differentiate from herpes simplex gingivostomatitis (which affects anterior mouth and gums more prominently) and hand-foot-mouth disease (which has characteristic peripheral lesions) 2
Watch for rare complications: While uncommon, enterovirus infections can occasionally involve the central nervous system, cardiovascular system, or cause aseptic meningitis 1